# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-22-025259
Filing Date
2022-11-16
Accepted
2022-11-16 11:34:58
Documents
47
Period of Report
2022-11-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | eypt-20221116.htm iXBRL | 8-K | 55272
2 | EX-99.1 | eypt-ex99_1.htm | EX-99.1 | 25264
3 | GRAPHIC | eypt-ex99_1s1.jpg | GRAPHIC | 38446
4 | GRAPHIC | eypt-ex99_1s2.jpg | GRAPHIC | 139230
5 | GRAPHIC | eypt-ex99_1s3.jpg | GRAPHIC | 77041
6 | GRAPHIC | eypt-ex99_1s4.jpg | GRAPHIC | 61115
7 | GRAPHIC | eypt-ex99_1s5.jpg | GRAPHIC | 55215
8 | GRAPHIC | eypt-ex99_1s6.jpg | GRAPHIC | 84265
9 | GRAPHIC | eypt-ex99_1s7.jpg | GRAPHIC | 64598
10 | GRAPHIC | eypt-ex99_1s8.jpg | GRAPHIC | 71790
11 | GRAPHIC | eypt-ex99_1s9.jpg | GRAPHIC | 29135
12 | GRAPHIC | eypt-ex99_1s10.jpg | GRAPHIC | 63707
13 | GRAPHIC | eypt-ex99_1s11.jpg | GRAPHIC | 82330
14 | GRAPHIC | eypt-ex99_1s12.jpg | GRAPHIC | 95834
15 | GRAPHIC | eypt-ex99_1s13.jpg | GRAPHIC | 102828
16 | GRAPHIC | eypt-ex99_1s14.jpg | GRAPHIC | 61620
17 | GRAPHIC | eypt-ex99_1s15.jpg | GRAPHIC | 69449
18 | GRAPHIC | eypt-ex99_1s16.jpg | GRAPHIC | 41066
19 | GRAPHIC | eypt-ex99_1s17.jpg | GRAPHIC | 68111
20 | GRAPHIC | eypt-ex99_1s18.jpg | GRAPHIC | 76801
21 | GRAPHIC | eypt-ex99_1s19.jpg | GRAPHIC | 64112
22 | GRAPHIC | eypt-ex99_1s20.jpg | GRAPHIC | 22647
23 | GRAPHIC | eypt-ex99_1s21.jpg | GRAPHIC | 95537
24 | GRAPHIC | eypt-ex99_1s22.jpg | GRAPHIC | 73740
25 | GRAPHIC | eypt-ex99_1s23.jpg | GRAPHIC | 27762
26 | GRAPHIC | eypt-ex99_1s24.jpg | GRAPHIC | 56296
27 | GRAPHIC | eypt-ex99_1s25.jpg | GRAPHIC | 26745
28 | GRAPHIC | eypt-ex99_1s26.jpg | GRAPHIC | 74455
29 | GRAPHIC | eypt-ex99_1s27.jpg | GRAPHIC | 51931
30 | GRAPHIC | eypt-ex99_1s28.jpg | GRAPHIC | 40023
31 | GRAPHIC | eypt-ex99_1s29.jpg | GRAPHIC | 65794
32 | GRAPHIC | eypt-ex99_1s30.jpg | GRAPHIC | 69798
33 | GRAPHIC | eypt-ex99_1s31.jpg | GRAPHIC | 59788
34 | GRAPHIC | eypt-ex99_1s32.jpg | GRAPHIC | 57679
35 | GRAPHIC | eypt-ex99_1s33.jpg | GRAPHIC | 68250
36 | GRAPHIC | eypt-ex99_1s34.jpg | GRAPHIC | 38049
| Complete submission text file | 0000950170-22-025259.txt |  | 3203382

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
37 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | eypt-20221116_lab.xml | EX-101.LAB | 12806
38 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | eypt-20221116.xsd | EX-101.SCH | 2475
39 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | eypt-20221116_pre.xml | EX-101.PRE | 9457
41 | EXTRACTED XBRL INSTANCE DOCUMENT | eypt-20221116_htm.xml | XML | 4523

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 221394015
SIC: 3826 Laboratory Analytical Instruments